Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Hepatol. Jul 27, 2022; 14(7): 1398-1407
Published online Jul 27, 2022. doi: 10.4254/wjh.v14.i7.1398
Table 2 Univariate analysis on time to development of death/clinical deterioration prior to liver transplant
Variable
n
Events
Cox univariate hazard ratio (95%CI)
P value
Age26568 (26%)1.018 (0.985, 1.053)0.28
Sex
Female13738 (28%)-
Male12830 (23%)0.84 (0.52, 1.37)0.49
Model for End-Stage Liver Disease26568 (26%)1.18 (1.14, 1.23)< 0.001
Body mass index26568 (26%)0.975 (0.941, 1.011)0.17
Renal replacement therapy
No23360 (26%)-
Yes328 (25%)3.20 (1.49, 6.88)0.003
Hypertension
No11329 (26%)-
Yes15239 (26%)1.15 (0.71, 1.88)0.57
Obstructive sleep apnea
No20346 (23%)-
Yes6222 (35%)1.10 (0.66, 1.85)0.72
Atrial fibrillation/Atrial flutter
No 25664 (25%)-
Yes83 (38%)2.97 (0.92, 9.61)0.069
Heart failure.
No24460 (25%)-
Yes188 (44%)1.81 (0.86, 3.82)0.12
Left ventricular ejection fraction26367 (25%)0.99 (0.96, 1.03)0.69
Estimated right ventricular systolic pressure19048 (25%)1.026 (0.997, 1.055)0.075
Aortic stenosis
No25767 (26%)-
Yes81 (13%)0.95 (0.13, 6.86)0.96
Aortic insufficiency
No26367 (25%)-
Yes21 (50%)1.38 (0.19, 10.04)0.75
Mitral regurgitation
No26167 (26%)-
Yes41 (25%)2.92 (0.40, 21.48)0.29
Tricuspid regurgitation
No25764 (25%)-
Yes84 (50%)3.50 (1.26, 9.72)0.016
CAD
No significant CAD19644 (22%)-
Mild or Moderate CAD4515 (33%)2.06 (1.14, 3.74)0.017
Severe CAD249 (38%)2.43 (1.17, 5.05)0.017
History of myocardial infarction
No25363 (25%)-
Yes125 (42%)2.29 (0.92, 5.74)0.076
History of coronary artery stenting
No25263 (25%)-
Yes135 (38%)1.86 (0.74, 4.66)0.19
History of coronary artery bypass grafting
No25464 (25%)-
Yes114 (36%)2.03 (0.73, 5.65)0.17
Hemoglobin A1c
< 5.65912 (20%)--
5.6-6.56219 (31%)1.11 (0.53, 2.32)0.79
> 6.55015 (30%)0.80 (0.37, 1.76)0.58
High-density lipoprotein
≥ 507522 (29%)-
< 5017641 (23%)1.18 (0.69, 2.01)0.54
Triglycerides
≤ 15024063 (26%)-
> 150152 (13%)0.49 (0.12, 2.00)0.32